ELLIO CX LIMITED
Company number 01336850 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: C (Guarded)
ELLIO CX LIMITED is currently solvent and up to date with its statutory filings, but its financial vital signs indicate a serious condition requiring close monitoring. The company remains a going concern only with the support of its parent group. Without a sustained improvement in trading performance or continued capital injections, the score could deteriorate.
Key Vital Signs
| Metric | 2024 | 2023 | Interpretation |
|---|---|---|---|
| Revenue | £240.7m | £340.0m | Sharp contraction of roughly 29%; like rapid weight loss, signalling loss of contracts and business volume. |
| Operating result | Loss of £79.4m | Loss of £62.3m | Deepening losses; the core operation is spending significantly more than it earns. |
| Net assets / Shareholders’ funds | £34.4m | £88.6m | Halved in one year; the financial cushion has been severely eroded. |
| Cash at bank | £1.18m | £2.04m | Low relative to turnover; a limited liquid buffer for unexpected shocks. |
| Parent capital injection | £30m | — | External life support that prevented a larger collapse in net assets. |
| Filing status | Up to date | Up to date | Administrative health is good; no overdue accounts or confirmation statements. |
The company is a wholly owned subsidiary (indirectly held) of a larger group. Force Bidco Limited and Capita Holdings Limited are recorded as persons with significant control, each holding more than 75% of shares and voting rights.
Diagnosis
The company operates in the contact centre and outsourcing sector. According to its own strategic report, revenue fell from £340.0m in 2023 to £240.7m in 2024, mainly due to contract losses. The operating loss widened from £62.3m to £79.4m over the same period, driven by lower volumes and asset impairments.
In plain terms, the business is losing clients and the cost of keeping the lights on exceeds the income coming in. The balance sheet still shows more assets than liabilities (positive net assets), but the buffer has been cut by roughly half. A £30m capital injection from the parent company offset part of the decline, meaning the company is currently being kept stable by external transfusion rather than by its own operations.
The company is not insolvent, but it is financially fragile. Its condition is best described as chronic revenue decline with acute operating losses, managed through parental support.
Prognosis
Guarded. If contract losses continue and the operating loss persists, net assets could fall further, increasing the risk that additional parent funding will be required. Stabilisation depends on:
- Winning replacement contracts to restore revenue;
- Reducing the cost base to match lower volumes; and
- Continued willingness and ability of the ultimate parent to provide financial support.
Recommendations
- Revenue recovery: Prioritise new business development and client retention to replace lost contracts and stop the revenue decline.
- Cost restructuring: Align staffing, overheads, and asset base with current revenue levels to reduce the operating loss.
- Liquidity monitoring: Prepare monthly cash-flow forecasts and maintain an open line with the parent company regarding any further funding requirements.
- Asset review: Continue to assess underperforming or impaired assets, and consider divesting non-core investments where appropriate.
- Board oversight: Ensure directors receive regular, detailed reporting on contact-centre segment performance and on the group’s commitment to ongoing support.
- Stakeholder confidence: Communicate clearly with clients, suppliers, and employees to maintain confidence during the turnaround period.